Tech

Digital biomarkers are healthcare’s next frontier – TechCrunch

blood pressure, body Temperature, hemoglobin A1c levels, and other biomarkers have been used to track disease for decades. While this information is essential to the management of chronic disease, this and many other physiological measurements are typically collected only periodically, making it difficult to reliably detect meaningful changes early on.

In addition, biomarkers extracted from blood require inconvenient blood draws, can be expensive to analyze, and again are not always timely.

In the past, constantly monitoring a person’s vital signs meant they had to be in a hospital. But that’s no longer true. Digital biomarkers, collected by wearable sensors or via a device, offer healthcare providers a wealth of traditional and emerging data to accurately monitor and even predict a patient’s disease progression.

With cloud-based servers and sophisticated but inexpensive sensors both on and off the body, patients can be monitored more effectively at home than in a hospital, especially when the sensor data is analyzed using artificial intelligence (AI) and machine learning technology.

Opportunities for digital biomarkers

A great opportunity for digital biomarkers lies in the treatment of neurodegenerative diseases such as mild cognitive impairment, Alzheimer’s and Parkinson’s.

Neurodegenerative diseases are an important target for the development of digital biomarkers due to the lack of readily available indicators that can help providers to diagnose and treat these diseases. For example, a definitive diagnosis for Alzheimer’s disease now generally requires positron emission tomography (PET), magnetic resonance imaging (MRI), or other imaging tests, as is often the case expensive and not always accurate or reliable.

Cost savings and other benefits

Digital biomarkers have the potential to create significant value for healthcare providers, companies, and most importantly, patients and families by detecting and slowing the progression of these diseases.

Digital biomarkers are healthcare’s next frontier – TechCrunch Source link Digital biomarkers are healthcare’s next frontier – TechCrunch

Related Articles

Back to top button